REGISTERED NUMBER: 12436550 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2025

FOR

COMPLIANT MEDICAL DEVICES LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

R J J Tully

REGISTERED OFFICE:

58 London Street

Whitchurch

RG28 7LN

REGISTERED NUMBER:

12436550 (England and Wales)

ACCOUNTANT:

Richard Kyte Associates

Chartered Certified Accountant

126 Weyhill Road

Andover

Hampshire

SP10 3BE

FIXED ASSETS

Tangible assets

4

4,876

6,741

CURRENT ASSETS

Debtors

5

226,765

242,744

Cash at bank

465,756

192,842

692,521

435,586

CREDITORS

Amounts falling due within one year

6

267,653

177,522

NET CURRENT ASSETS

424,868

258,064

TOTAL ASSETS LESS CURRENT LIABILITIES

429,744

264,805

PROVISIONS FOR LIABILITIES

7

1,219

1,620

NET ASSETS

428,525

263,185

CAPITAL AND RESERVES

Called up share capital

8

100

100

Retained earnings

9

428,425

263,085

SHAREHOLDERS' FUNDS

428,525

263,185

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 1 October 2025 and were signed by:

R J J Tully - Director

1.	STATUTORY INFORMATION

Compliant Medical Devices Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixture and Fittings

-

15% on cost

Computer equipment

-

33% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 5 ) .

4.	TANGIBLE FIXED ASSETS

Fixture

and

Computer

Fittings

equipment

Totals

£

£

£

COST

At 1 February 2024

685

11,877

12,562

Additions

-

1,324

1,324

At 31 January 2025

685

13,201

13,886

DEPRECIATION

At 1 February 2024

188

5,633

5,821

Charge for year

54

3,135

3,189

At 31 January 2025

242

8,768

9,010

NET BOOK VALUE

At 31 January 2025

443

4,433

4,876

At 31 January 2024

497

6,244

6,741

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.1.25

31.1.24

£

£

Trade debtors

217,394

147,020

Amounts owed by associates

9,371

-

Directors' current accounts

-

93,950

Prepayments

-

1,774

226,765

242,744

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.1.25

31.1.24

£

£

Trade creditors

7,314

20,535

Tax

154,689

95,811

Social security and other taxes

30,997

17,980

VAT

73,247

33,231

Other creditors

239

8,815

Directors' current accounts

17

-

Accrued expenses

1,150

1,150

267,653

177,522

7.	PROVISIONS FOR LIABILITIES

31.1.25

31.1.24

£

£

Deferred tax

1,219

1,620

Deferred

tax

£

Balance at 1 February 2024

1,620

Utilised during year

(401

)

Balance at 31 January 2025

1,219

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.1.25

31.1.24

value:

£

£

100

Ordinary

1

100

100

9.

RESERVES

Retained

earnings

£

At 1 February 2024

263,085

Profit for the year

505,108

Dividends

(339,768

)

At 31 January 2025

428,425

10.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2025 and 31 January 2024:

31.1.25

31.1.24

£

£

R J J Tully

Balance outstanding at start of year

93,950

-

Amounts advanced

95,105

93,950

Amounts repaid

(189,055

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

-

93,950

The loan outstanding at the beginning of the year together with additional loans made in the period to 31 May 2024 were all repaid prior to 31 October 2024. Interest was charged on the loans at the official rate as advised by HMRC.

11.	RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

12.	ULTIMATE CONTROLLING PARTY

The controlling party is R J J Tully.

Mr R J J Tully as the sole director of the company owned 100% of the share capital at the year end. At the balance sheet date there was a balance of £17 due to him.